Department of Radiology, Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea.
Sci Rep. 2023 Feb 1;13(1):1811. doi: 10.1038/s41598-023-28399-1.
In this study, we aimed to evaluate the benefits and losses of mammography with and without implant displacement (ID) and propose an appropriate imaging protocol for the screening of breasts with implants. We evaluated mammograms of 162 breasts in 96 patients including 71 breasts with biopsy-proven cancers. Mammography of each breast included standard MLO and ID MLO images. We reviewed the mammograms using clinical image quality criteria, which consist of parameters that evaluate the proper positioning of the breast and the image resolution. Standard MLO images showed significantly higher scores for proper positioning but showed significantly lower scores for image resolution than the ID MLO images. Moreover, standard MLO images showed significantly higher kVp, mAs, and compressed breast thickness than the ID MLO images. The organ dose was also higher in the standard MLO images than in the ID MLO images, but the difference was not statistically significant. In mammography with proven cancer, ID MLO images showed significantly higher degree of cancer visibility than standard MLO images. For screening mammography in patients with breast implants, ID MLO view alone is sufficient for MLO projection with reducing the patient's radiation dose without compromising the breast cancer detection capability, especially in dense breasts with subpectoral implants.
在这项研究中,我们旨在评估有和没有植入物移位(ID)的乳腺 X 线摄影的获益和损失,并为带有植入物的乳房筛查提出适当的成像方案。我们评估了 96 名患者的 162 个乳房的乳腺 X 线照片,其中包括 71 个经活检证实患有癌症的乳房。每个乳房的乳腺 X 线摄影包括标准 MLO 和 ID MLO 图像。我们使用临床图像质量标准(包括评估乳房正确定位和图像分辨率的参数)来审查乳腺 X 线照片。标准 MLO 图像在正确定位方面的得分明显更高,但在图像分辨率方面的得分明显低于 ID MLO 图像。此外,标准 MLO 图像的千伏值(kVp)、毫安秒(mAs)和压缩乳房厚度均明显高于 ID MLO 图像。标准 MLO 图像的器官剂量也高于 ID MLO 图像,但差异无统计学意义。在有癌症的乳腺 X 线摄影中,ID MLO 图像显示出明显更高的癌症可见度比标准 MLO 图像。对于带有乳房植入物的患者的筛查性乳腺 X 线摄影,单独使用 ID MLO 视图对于 MLO 投影就足够了,可以在不影响乳腺癌检测能力的情况下减少患者的辐射剂量,特别是在带有胸肌下植入物的致密乳房中。